Double germline mutations in the RET proto-oncogene in MEN 2A and MEN 2B kindreds

Experimental and Clinical Endocrinology and Diabetes

Volumn 114, Issue 4, 2006, Pages 192-196

  Dvorakova, S ^a   Vaclavikova, E ^a   Ryska, A ^b   Cap, J ^b   Vlcek, P ^b   Duskova, J ^b   Kodetova, D ^b   Holub, V ^a   Novak, Z ^a   Bendlova, B ^a  

^a INSTITUTE OF ENDOCRINOLOGY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Cancer; Medullary thyroid carcinoma; Multiple germline mutations; RET proto oncogene; Thyroid

Indexed keywords

PROTEIN RET;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; EXON; FEMALE; GENE MUTATION; GENE SEQUENCE; GERM LINE; HUMAN; HUMAN TISSUE; MALE; NEUROFIBROMATOSIS; PEDIGREE ANALYSIS; PRIORITY JOURNAL; PROTO ONCOGENE; SCHOOL CHILD; SIPPLE SYNDROME;

ADOLESCENT; ADULT; ALLELES; AMINO ACID SUBSTITUTION; COHORT STUDIES; EXONS; FEMALE; GERM-LINE MUTATION; HUMANS; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B; PEDIGREE; PROTO-ONCOGENE PROTEINS C-RET; THYROID NEOPLASMS;

EID: 33744920072     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-924071     Document Type: Article

References (18)

1. Bartsch DK, Hasse C, Schug C, Barth P, Rothmund M, Hoppner W. A RET double mutation in the germline of a kindred with FMTC. Exp Clin Endocrinol Diabetes 2000; 108: 128-132
2. Berndt I, Reuter M, Saller B, Frank-Raue K, Groth P, Grussendorf M, Raue F, Ritter MM, Hoppner W. A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A. J Clin Endocrinol Metab 1998; 83: 770-774
3. Brauer VF, Scholz GH, Neumann S, Lohmann T, Paschke R, Koch CA. RET germline mutation in codon 791 in a family representing 3 generations from age 5 to age 70 years: should thyroidectomy be performed? Endocr Pract 2004; 10: 5-9
4. Fitze G, Schierz M, Bredow J, Saeger HD, Roesner D, Schackert HK. Various penetrance of familial medullary thyroid carcinoma in patients with RET protooncogene codon 790/791 germline mutations. Ann Surg 2002; 236: 570-575
5. Gimm O, Niederle BE, Weber T, Bockhorn M, Ukkat J, Brauckhoff M, Thanh PN, Frilling A, Klar E, Niederle B, Dralle H. RET proto-oncogene mutations affecting codon 790/791: a mild form of multiple endocrine neoplasia type 2A syndrome? Surgery 2002; 132: 952-959
6. Hansford JR, Mulligan LM. Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis. J Med Genet 2000; 37: 817-827
7. Ishizaka Y, Itoh F, Tahira T, Ikeda I, Sugimura T, Tucker J, Fertitta A, Carrano AV, Nagao M. Human ret proto-oncogene mapped to chromosome 10q11.2. Oncogene 1989; 4: 1519-1521
8. Ito S, Iwashita T, Asai N, Murakami H, Iwata Y, Sobue G, Takahashi M. Biological properties of ret with cysteine mutations correlate with multiple endocrine neoplasia type 2A, familial medullary thyroid carcinoma, and Hirschsprung's disease phenotype. Cancer Res 1997; 57: 2870-2872
9. Iwashita T, Kato M, Murakami H, Asai N, Ishiguro Y, Ito S, Iwata Y, Kawai K, Asai M, Kurokawa K, Kajita H, Takahashi M. Biological and biochemical properties of ret with kinase domain mutations identified in multiple endocrine neoplasia type 2B and familial medullary thyroid carcinoma. Oncogene 1999; 18: 3919-3922
10. Jindrichova S, Vcelak J, Vlcek P, Neradilova M, Nemec J, Bendlova B. Screening of six risk exons of the RET proto-oncogene in families with medullary thyroid carcinoma in the Czech Republic. J Endocrinol 2004; 183: 257-265
11. Kitamura Y, Scavarda N, Wells SA Jr, Jackson CE, Goodfellow PJ. Two maternally derived missense mutations in the tyrosine kinase domain of the RET protooncogene in a patient with de novo MEN 2B. Hum Mol Genet 1995; 4: 1987-1988
12. Koch CA, Huang SC, Vortmeyer AO, Zhuang Z, Chrousos GP, Pacak K. A patient with MEN 2 and multiple mutations of RET in the germline. Exp Clin Endocrinol Diabetes 2000; 108; 493
13. Menko FH, van der Luijt RB, de Valk IA, Toorians AW, Sepers JM, van Diest PJ, Lips CJ. Atypical MEN type 2B associated with two germline RET mutations on the same allele not involving codon 918. J Clin Endocrinol Metab 2002; 87: 393-397
14. Miyauchi A, Futami H, Hai N, Yokozawa T, Kuma K, Aoki N, Kosugi S, Sugano K, Yamaguchi K. Two germline missense mutations at codons 804 and 806 of the RET proto-oncogene in the same allele in a patient with multiple endocrine neoplasia type 2B without codon 918 mutation. Jpn J Cancer Res 1999; 90: 1-5
15. Nunes AB, Ezabella MC, Pereira AC, Krieger JE, Toledo SP. A novel Val648Ile substitution in RET protooncogene observed in a Cys634Arg multiple endocrine neoplasia type 2A kindred presenting with an adrenocorticotropin- producing pheochromocytoma. J Clin Endocrinol Metab 2002; 87: 5658-5661
16. Poturnajova M, Altanerova V, Kostalova L, Breza J, Altaner C. Novel germline mutation in the transmembrane region of RET gene close to Cys634Ser mutation associated with MEN 2A syndrome. J Mol Med 2005; 83: 287-295
17. Robledo M, Gil L, Pollan M, Cebrian A, Ruiz S, Azanedo M, Benitez J, Menarguez J, Rojas JM. Polymorphisms G691S/S904S of RET as genetic modifiers of MEN 2A. Cancer Res 2003; 63: 1814-1817
18. Tessitore A, Sinisi AA, Pasquali D, Cardone M, Vitale D, Bellastella A, Colantuoni V. A novel case of multiple endocrine neoplasia type 2A associated with two de novo mutations of the RET protooncogene. J Clin Endocrinol Metab 1999; 84: 3522-3527